Active Supportive Care and Symptom Management Grants
PI Name |
Organization - Company | Title | FOA |
|---|---|---|---|
| Dantzer, Robert | University Of Tx Md Anderson Can Ctr | The Metabolic Basis of Cancer-Related Fatigue | PA-18-484: NIH Research Project Grant |
| Darmani, Nissar A | Western University Of Health Sciences | Substance P tachykininergic NK1 receptor emetic signal transduction pathways | PA-16-160: NIH Research Project Grant |
| El-Jawahri, Areej | Massachusetts General Hospital | Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation | PA-16-160: NIH Research Project Grant |
| Enzinger, Andrea C | Dana-Farber Cancer Inst | Development of A Mindfulness-Based Mobile Health Intervention for Patients Coping with Pain from Advanced Malignancies | PA-18-946: Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain |
| Fortier, Michelle | University Of California-Irvine | Innovative Pain and Symptom Management Program for Children with Cancer | PA-16-160: NIH Research Project Grant |
| Geisler, Stefanie | Washington University | Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Gewandter, Jennifer | University Of Rochester | Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial | PA-18-159: Mechanisms, Models, Measurement, and Management in Pain Research |
| Gray, Robert J | Dana-Farber Cancer Inst | Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV) | RFA-CA-17-052: Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability |
| Hanks, Brent Allen | Duke University | Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities | PAR-19-325: Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
| Heijnen, Cobi J | University Of Tx Md Anderson Can Ctr | Mesenchymal Stem Cells to Repair Chemobrain | RFA-CA-15-008: Research Answers to NCI's Provocative Questions |
| Herrmann, Joerg | Mayo Clinic Rochester | TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial | PA-18-003: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
| Hill, Deirdre | University Of New Mexico Health Scis Ctr | Chronic Kidney Disease Development in Cancer Treatment and Survival | PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
| Hinds, Pamela S | Children'S Research Institute | Longitudinal, multimodal assessment of neuropsychological functioning in children diagnosed with high-risk acute lymphoblastic leukemia (HR-ALL): Using early changes to predict later impairment | PA-16-160: NIH Research Project Grant |
| Hoffman, Amy Jude | University Of Nebraska Medical Center | Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients | PA-16-160: NIH Research Project Grant |
| Hu, Shuiying | Ohio State University | Prevention of paclitaxel-induced peripheral neuropathy with nilotinib | RFA-CA-18-019: Research Answers to National Cancer Institute's (NCI) Provocative Questions |